FDA Warns Three Baby-Formula Makers Over Violations in Production
By Sabela Ojea
The U.S. Food and Drug Administration issued warning letters to baby-formula manufacturers Reckitt & Benckiser's Mead Johnson Nutrition, Perrigo Wisconsin and ByHeart over their infant formulas.
The U.S. regulator said the three companies violated infant formula regulations, based on data compiled from a number of inspections of their facilities over the past few months.
Each company will have 15 working days to explain what corrective actions they are taking, the FDA said.
The FDA isn't advising parents and caregivers to discard or avoid purchasing any particular infant formula at this time. However, its aim is to make sure infant formula is being produced "under the safest conditions possible."
"The FDA is issuing these letters...to reinforce to these firms the importance of instituting and maintaining appropriate corrective actions when they detect pathogens to ensure compliance with the FDA's laws and regulations," it said.
In December of last year then again in February and March, the FDA initiated formula recalls to remove product potentially contaminated with the bacteria Cronobacter sakazakii.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
August 30, 2023 17:12 ET (21:12 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Is ServiceNow Stock a Buy After Earnings and Its Investor Day?
-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
After Earnings, Is Coke Stock a Buy, a Sell, or Fairly Valued?
-
Disney Earnings: Improved Streaming Results Come at the Expense of Continued Linear Weakness
-
Apple: We Expect New Models and New Chip to Spur Return to iPad Growth
-
Palantir Earnings: AI Platform Drives Strong Start to 2024
-
What I Hope My 14-Year-Old Learned at Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Amazon Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Dividend Stocks
-
3 Stocks With High Dividend Yields That Warren Buffett Likes